Download PDF
Thromb Haemost 1968; 19(01/02): 221-225
DOI: 10.1055/s-0038-1651199
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Inactivation of Tissue Thromboplastin by Ultraviolet Irradiation

S Åtland
1   Departments of Physics and Microbiology, University of Oslo, Blindern, Oslo 3, Norway
,
M Hvatum   *
1   Departments of Physics and Microbiology, University of Oslo, Blindern, Oslo 3, Norway
,
H Prydz
1   Departments of Physics and Microbiology, University of Oslo, Blindern, Oslo 3, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

Solutions of partially purified tissue thromboplastin have been irradiated with UV light of different wavelengths, and the resulting reduction in the procoagulant activity has been measured. The activity decreased as an exponential function of the dose. The action spectrum obtained was closely similar to the UV absorption spectrum of the thromboplastic preparations and had a maximum between 270-290 nm. The data suggested that the reduction in the procoagulant activity was caused by absorption of radiation energy in the protein part of the thromboplastic structure.

* Research Fellow of the Norwegian Council of Cardiovascular Diseases.


 

  • References

  • 1 Hvatum M, Prydz H. Studies on tissue thromboplastin. I. Solubilization with sodium deoxy-cholate. Biochim. biophys. Acta (Amst.) 1966; 130: 92
    PubMedGoogle Scholar
  • 2 Wooldridge L.C. On the chemistry of the blood other scientific papers. p. 135. Kegan Paul Trench Trübner London Cit. E.C., Hecht 1893 7
    PubMed
  • 3 Mills C.A. Chemical nature of tissue coagulins. J. biol. Chem. 1921; 46: 135
    PubMedGoogle Scholar
  • 4 Cohen S.S, Chargaff E. Studies on the chemistry of blood coagulation. IX. The thrombo-plastic protein from lungs. J. biol. Chem. 1940; 136: 243
    PubMedGoogle Scholar
  • 5 Studer A. Festschrift Barell. Hoffmann-La Roche, Basel p. 229. Cit. E. C. Hecht 1946 7
    PubMed
  • 6 Deutsch E, Irsigler K, Lomoschitz H. Studien über Gewebethromboplastin 1. Reinigung, chemische Charakterisierung und Trennung in einen Eiweiß- und Lipoidanteil. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 12: 12
    PubMedGoogle Scholar
  • 7 Hecht E.C. Lipids in blood clotting. Charles C. Thomas; Springfield USA: 1965: 328
    Google Scholar
  • 8 Hecht E. C: Chemical nature of human brain thromboplastin. Nature (Lond.) 1967; 214: 197
    CrossrefPubMedGoogle Scholar
  • 9 Hecht E.C, Cho M.H, Seegers W.H. Thromboplastin: Nomenclature and preparation of protein-free material different from platelet factor 3 or lipid activator. Amer. J. Physiol. 1958; 193: 584
    PubMedGoogle Scholar
  • 10 Lowry O.H, Rosebrough N.J, Farr A.L, Randall R.J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 1951; 193: 265
    PubMedGoogle Scholar
  • 11 Chen Jr. P.S, Toribara T.Y, Warner H. Microdetermination of phosphorus. Anal. Chem. 1956; 28: 1756
    CrossrefPubMedGoogle Scholar
  • 12 Kabat E.A, Mayer M.M. Experimental Immunochemistryg. Charles C. Thomas; Springfield, Illionois: 1961: 505
    Google Scholar
  • 13 Svennerholm L. Quantitative estimation of sialic acid with the resorcinol-HCl method. Biochim. biophys. Acta (Amst.) 1957; 24: 604
    CrossrefPubMedGoogle Scholar
  • 14 Gibbons M.N. The determination of methylpentoses. Analyst 1955; 90: 268
    PubMedGoogle Scholar